Decision-Aid for Renal Therapy Pilot Trial



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:70 - Any
Updated:9/13/2018
Start Date:March 16, 2017
End Date:July 1, 2018

Use our guide to learn which trials are right for you!

Decision-Aid for Renal Therapy Pilot Trial (DART Pilot Trial)

Successful communication between patients, caregivers, and physicians can improve how
patients feel about their treatment. Our recent studies of older dialysis patients find,
however, that many patients do not engage in this type of communication about treatment
options. This study aims to determine whether the Decision-Aid for Renal Therapy (DART), a
web-based program, can improve shared decision-making (decisions where patients are actively
engaged) among patients, caregivers, and physicians, and improve certainty and satisfaction
in treatment decisions.

Successful end-of-life communication between patients, caregivers, and physicians is
associated with superior psychosocial outcomes, less intensive treatment, greater
satisfaction, and higher likelihood of death at home. The Decision-Aid for Renal Therapy
(DART) is an interactive web-based decision-aid that can empower patients and caregivers to
select the treatment choice for chronic kidney disease that best suits them. DART was
developed using a rigorous, validated, patient-engaged process and helps clarify
decision-points and tradeoffs by providing individualized information about outcomes that
matter most to patients. DART is designed to promote shared decision-making between patients,
caregivers, and physicians and align preferences with treatment received.

Although proven effective and in current use in the general population, DART's effectiveness
in an older population is unclear. The purpose of this project is to conduct a pilot study of
DART's feasibility and effectiveness to improve end-of-life planning and shared
decision-making among older end-stage renal disease patients.

Inclusion Criteria:

- Chronic kidney disease stages 4 or 5, not currently on dialysis

- Age >=70

- English-speaking

- Willingness to be randomized to DART

- Able to sign informed consent

- 5-year kidney failure risk probability > 15% using [www.kidneyfailurerisk.com]

- Glomerular filtration rate (GFR) < 30

Exclusion Criteria:

- Non-English speaking
We found this trial at
2
sites
Brighton, Massachusetts 02135
Phone: 617-789-3168
?
mi
from
Brighton, MA
Click here to add this to my saved trials
800 Washington St
Boston, Massachusetts 02111
(617) 636-5000
Tufts Medical Center Tufts Medical Center is an internationally-respected academic medical center – a teaching...
?
mi
from
Boston, MA
Click here to add this to my saved trials